Domaines de recherche divers - page 21 - Publications Scientifiques

Dernière publication 11/10/2012

An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphyla

Background Peanut allergy causes severe type 1 hypersensitivity reactions and conventional immunotherapy against peanut allergy is associated...

Array
(
    [id_prestablog_news] => 428
    [id_shop] => 1
    [date] => 2012-10-11 00:00:00
    [date_modification] => 2024-02-09 14:15:11
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 850
    [id_lang] => 2
    [title] => An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphyla
    [paragraph] => An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
    [content] => 
Authors
Philipp Starkl, Ferdinand Felix, Durga Krishnamurthy, Caroline Stremnitzer, Franziska Roth-Walter, Sara R. Prickett et al.



 Lab
Medical University of Vienna, Vienna, Austria / The Alfred Hospital and Monash University, Melbourne, Australia


Journal
Clinical & Experimental Allergy


Abstract
Background
Peanut allergy causes severe type 1 hypersensitivity reactions and conventional immunotherapy against peanut allergy is associated with a high risk of anaphylaxis.

Objective
Our current study reports proof of concept experiments on the safety of a stably denatured variant of the major peanut allergen Ara h 2 for immunotherapy. We determined the impact of structure loss of Ara h 2 on its IgE binding and basophil degranulation capacity, T-cell reactivity as well as anaphylactic potential.

Methods
The secondary structure of untreated and reduced/alkylated Ara h 2 variants was determined by circular dichroism spectroscopy. We addressed human patient IgE binding to Ara h 2 by ELISA and Western blot experiments. RBL-SX38 cells were used to test the degranulation induced by untreated and reduced/alkylated Ara h 2. We assessed the anaphylactic potential of Ara h 2 variants by challenge of sensitized BALB/c mice. T cell reactivity was investigated using human Ara h 2 specific T cell lines and splenocytes isolated from sensitized mice.

Results
Reduction/alkylation of Ara h 2 caused a decrease in IgE binding capacity, basophil degranulation and anaphylactic potential in vivo. However, the human T cell response to reduced/alkylated and untreated Ara h 2 was comparable. Mouse splenocytes showed higher metabolic activity upon stimulation with reduced/alkylated Ara h 2 and released similar IL-4, IL-13, and IFN? levels upon treatment with either Ara h 2 variant.

Conclusion and Clinical Relevance
Reduced/alkylated Ara h 2 might be a safer alternative than native Ara h 2 for immunotherapeutic treatment of peanut allergic patients.

    [meta_description] => 
    [meta_keywords] => http://onlinelibrary.wiley.com/doi/10.1111/cea.12031/abstract
    [meta_title] => 
    [link_rewrite] => an-unfolded-variant-of-the-major-peanut-allergen-ara-h-2-with-decreased-anaphylactic-potential
    [actif_langue] => 1
    [read] => 655
    [count_comments] => 0
    [id] => 428
    [categories] => Array
        (
            [26] => Array
                (
                    [id_prestablog_categorie] => 26
                    [title] => Domaines de recherche divers
                    [link_rewrite] => Domaines-de-recherche-divers
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
    [link_for_unique] => 1
)
1
En lire plus

Filtres

Tout effacer

Categories

View all products

Applications

Dates

<< 1 ... 21 22 23 24 25 >>